Member Info for WeTookPelham

A good few decent sized trades, decent bit of blue, large sell(?) after the bell, SP still held up (i think?).
Either way, a distinctly different day of late. Perhaps Hasiba, despite his motivations, has a point!???

I'm with TF, perplexed also. Maybe some admin errors RE the duplicate address (is the one difference "England' in the before and after?).

But mainly perplexed as to why they've only RNS'd now?

RE my last post, can someone tell me if I'm reading it correctly?

On "12 Aug 2022"
"Registered office address changed from John Eccles House Robert Robinson Avenue Oxford Science Park Oxford OX4 4GP United Kingdom to Bellhouse Building Sanders Road Oxford OX4 4GD on 12 August 2022"

Then on "15 Aug 2022"
"Registered office address changed from Bellhouse Building Sanders Road Oxford OX4 4GD England to Bellhouse Building Sanders Road Oxford Science Park Oxford OX4 4GD on 15 August 2022"
(I.e. registered address changed but the actual address is still the same?)

And yet we only get the RNS today? And intraday too?

Meanwhile, with Zakari:
"12 Aug 2022"
"Registered office address changed from John Eccles House Robert Robinson Avenue Oxford OX4 4GP England to Bellhouse Building Sanders Road Oxford OX4 4GD on 12 August 2022"

Hmmm... curiouser and curiouser?

https://find-and-update.company-information.service.gov.uk/company/06564638/filing-history

So Zakari Therapeutics and now Scancell Holdings have changed their registered office to match?

https://find-and-update.company-information.service.gov.uk/company/13408042/filing-history

Lol... My thoughts exactly. Especially as it was an intra day RNS! But why was this released intra day anyway?

Anyhow, any real significance RE change if office?

Nice find Cleaner world, the paper the article is based around is certainly worth a read.

https://www.embopress.org/doi/full/10.15252/emmm.202215821

Edit...by number I mean size of team.

But also, has some of o' Tear's responsibilities been taken over by all the recent recruitment?

So does anyone know the number of the scientific team now?
And is this the most senior role so far? I feel like it's the 3rd of other similar roles recruited so far?

I'm sure I mentioned this a few months ago...keep up at the back there :)

Isn't it just a retweet of Bermuda's tweet?
For me personally it's still not enough communication.

Thanks TF, can't really comment on the science but I wonder how significant Professor Durant leaving the university is?

I think the comparison came about because of market reaction to news, and how anemic Scancells reaction normally is in comparison, rather than competitors.

Fair point C7.

P.s. I'm not saying they should over hype at all, but simply give context and simplify them.

RNS Titles??

So I was thinking about this, as yet another very bizzare muted reaction to the SP. Maybe it's nothing important but for me are the RNS tiltes to me are simply too specific?

What I mean is that the only people that would have understood the the significance of yesterdays RNS would be us Scancell long/medium term holders.

I believe lots of people invest based on news announcements and seeing keywords like "cancer", "vaccine", "trial", "safety" would certainly attract interest. Whilst it would attract the traders...attention is still attention. But yet yesterdays announcment was "First patient dosed in Cohort 2 of the ModiFY" which IMO means nothing to the outsider.

Why didn't the RNS have titles such as:
https://www.marketwatch.com/story/scancell-starts-dosing-second-cohort-for-cancer-treatment-trial-271660657228
Or:
https://www.sharesmagazine.co.uk/news/market/1660668696804583900/in-brief-scancell-doses-first-patient-in-modi-1-cancer-trial

Looking at the RNS historys, the titles are very dour and to the point, and to a non medical , non scancell layman the tiles make little sense, they similarily don't have key simple words explaining the context of the news.
https://www.lse.co.uk/rns/SCLP/

Then burble posted this:
"Burble

Posts: 772

Price: 13.25

No Opinion

RE: Trial DesignToday 06:35
Likewise. Though selfish me thinks the longer this goes under the radar, the more I can have at these levels."

Part of me wonders if it's deliberate, i.e. to keep it under the radar?

16/8/2022
15:56 markingtime: I've checked and the current Modi-1 trial design is given on p12 of Trinity's note in April. As inanaco says, once that hurdle is passed the trial expands quite rapidily with 3 arms initially and 6 arms after cohorts 3&4 pass safety checks.It will be "eyes down" once Cohort 4 has completed...

Obviously BionTech will be fully aware of Covidity, how interested they are, if at all, is a key question.

But despite BionTech and Pfziers huge wealth, size, ability to upscale etc. they would (IMO) still have somewhat of a headstart and DNA vaccine expertise if they decided to partner with Scancell.

That's an eye opening article on Bloomberg @cleanerworld, it has somewhat answered my question RE weather mRNA vaccines could work as pan universal vaccine:

"“Even with the highly flexible platform of mRNA, which is more flexible than virtually anything we’ve had before, it’s going to be very difficult to keep up with the pace of newly evolving variants,” Fauci said in an interview. “Which gets us to the question: What about a pan-coronavirus vaccine?”

"... tying up loose ends" gives me some glimmer of hope going into the weekend, wether it's deserved or not!